Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Whady Hueb

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Coronary Artery Disease|April 18, 2019
Effect of ischemic preconditioning on cardiovascular outcomes in patients with symptomatic coronary artery disease: a cohort studyRosa M Rahmi, Whady Hueb, Paulo C Rezende, et al.
Circulation|September 13, 2003
Relative cost comparison of treatments for coronary artery disease: the First Year Follow-Up of MASS II StudyDesiderio Favarato, Whady Hueb, Bernard J Gersh, et al.
Coronary Artery Disease|October 29, 2008
Impact of metabolic syndrome on the outcome of patients with stable coronary artery disease: 2-year follow-up of the MASS II studyNeuza H Lopes, Felipe S Paulitsch, Alexandre C Pereira, et al.
Clinical Cardiology|December 5, 2025
Underestimation of Stent Efficacy: Untreated Artery Events Distort Coronary Intervention OutcomesMauricio Rigodanzo Mocha, Whady Hueb, Paulo Cury Rezende, et al.
Journal of the American College of Cardiology|September 5, 2006
Clinical judgment and treatment options in stable multivessel coronary artery disease: results from the one-year follow-up of the MASS II (Medicine, Angioplasty, or Surgery Study II)Alexandre C Pereira, Neuza H M Lopes, Paulo R Soares, et al.
Thrombosis Research|July 3, 2007
Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularizationAlexandre C Pereira, Ayumi A Miyakawa, Neuza H M Lopes, et al.
Coronary Artery Disease|December 19, 2006
Effect of a hypoglycemic agent on ischemic preconditioning in patients with type 2 diabetes and stable angina pectorisWhady Hueb, Augusto H Uchida, Bernard J Gersh, et al.
Journal of the American College of Cardiology|May 18, 2004
The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year resultsWhady Hueb, Paulo R Soares, Bernard J Gersh, et al.
Journal of the American College of Cardiology|December 8, 2018
SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM TrialRodrigo B Esper, Michael E Farkouh, Expedito E Ribeiro, et al.
Cost Effectiveness and Resource Allocation : C/E|November 10, 2018
Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trialSara Michelly Gonçalves Brandão, Paulo Cury Rezende, Hans-Peter Brunner-La Rocca, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Coronary Artery Disease|April 18, 2019
Effect of ischemic preconditioning on cardiovascular outcomes in patients with symptomatic coronary artery disease: a cohort studyRosa M Rahmi, Whady Hueb, Paulo C Rezende, et al.
Circulation|September 13, 2003
Relative cost comparison of treatments for coronary artery disease: the First Year Follow-Up of MASS II StudyDesiderio Favarato, Whady Hueb, Bernard J Gersh, et al.
Coronary Artery Disease|October 29, 2008
Impact of metabolic syndrome on the outcome of patients with stable coronary artery disease: 2-year follow-up of the MASS II studyNeuza H Lopes, Felipe S Paulitsch, Alexandre C Pereira, et al.
Clinical Cardiology|December 5, 2025
Underestimation of Stent Efficacy: Untreated Artery Events Distort Coronary Intervention OutcomesMauricio Rigodanzo Mocha, Whady Hueb, Paulo Cury Rezende, et al.
Journal of the American College of Cardiology|September 5, 2006
Clinical judgment and treatment options in stable multivessel coronary artery disease: results from the one-year follow-up of the MASS II (Medicine, Angioplasty, or Surgery Study II)Alexandre C Pereira, Neuza H M Lopes, Paulo R Soares, et al.
Thrombosis Research|July 3, 2007
Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularizationAlexandre C Pereira, Ayumi A Miyakawa, Neuza H M Lopes, et al.
Coronary Artery Disease|December 19, 2006
Effect of a hypoglycemic agent on ischemic preconditioning in patients with type 2 diabetes and stable angina pectorisWhady Hueb, Augusto H Uchida, Bernard J Gersh, et al.
Journal of the American College of Cardiology|May 18, 2004
The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year resultsWhady Hueb, Paulo R Soares, Bernard J Gersh, et al.
Journal of the American College of Cardiology|December 8, 2018
SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM TrialRodrigo B Esper, Michael E Farkouh, Expedito E Ribeiro, et al.
Cost Effectiveness and Resource Allocation : C/E|November 10, 2018
Comparative cost-effectiveness of surgery, angioplasty, or medical therapy in patients with multivessel coronary artery disease: MASS II trialSara Michelly Gonçalves Brandão, Paulo Cury Rezende, Hans-Peter Brunner-La Rocca, et al.
Pageof 10